Veterinary Medicine Information website

NOBIVAC RL ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ

Authorised
  • Rabies virus, strain Pasteur RIV, Inactivated
  • Leptospira interrogans, serovar Copenhageni, strain 820K, Inactivated
  • Leptospira interrogans, serovar Portlandvere, strain Ca-12-000, Inactivated

Product identification

Medicine name:
NOBIVAC RL ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ
Active substance:
  • Rabies virus, strain Pasteur RIV, Inactivated
  • Leptospira interrogans, serovar Copenhageni, strain 820K, Inactivated
  • Leptospira interrogans, serovar Portlandvere, strain Ca-12-000, Inactivated
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Rabies virus, strain Pasteur RIV, Inactivated
    3.00
    international unit(s)
    /
    1.00
    millilitre(s)
  • Leptospira interrogans, serovar Copenhageni, strain 820K, Inactivated
    40.00
    Hamster protective Dose 80%
    /
    1.00
    millilitre(s)
  • Leptospira interrogans, serovar Portlandvere, strain Ca-12-000, Inactivated
    40.00
    Hamster protective Dose 80%
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Dog
      • Not applicable
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AL01
Authorisation status:
  • Valid
Authorised in:
  • Greece
Available in:
  • Greece
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Intervet Hellas M.A.E.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 27950/97/Κ2520/27-1-1998/K-0076101
Date of authorisation status change: